Regulations Governing Incentive Rewards for Research and Development of Pharmaceutical Technology Article 5
A Review Committee for pharmaceutical Research and Development ("Review Committee") shall be formed to review applications for incentive rewards submitted pursuant to these Regulations.The Review Committee shall have 9 to 13 members, which shall be jointly selected by the central competent health authority, the central competent industrial authority, representatives from technology industries, academic institutions, and the industrial sector, and related academicians.The members shall elect from among themselves a chairperson for the Review Committee.Positions on the Review Committee are not paid positions.The tasks of the Review Committee are as follows:1. Reviewing the qualifications of applicants for incentive rewards.2. Examining each application for an incentive reward.3. Determining the number of rewards to be issued and the number of reward points.4. Other matters that must be reviewed by the Review Committee pursuant to these Regulations.
中文原文 藥物科技研究發展獎勵辦法第5條
為審議依本辦法申請獎勵之案件，應組成藥物研發審議會（以下簡稱審議會）。
審議會置委員九人至十三人，由中央衛生主管機關、中央工業主管機關、科技相關代表、學術機構、工業界之代表及有關學者共同遴選組成。
審議會由委員相互推選一人為主席。
審議會委員均為無給職。
審議會之任務如下：
一、審查獎勵對象之資格。
二、審議各項獎勵申請案件。
三、核定獎勵名額及核給獎勵點數。
四、其他依本辦法應經審議會審議之事項。
審議會置委員九人至十三人，由中央衛生主管機關、中央工業主管機關、科技相關代表、學術機構、工業界之代表及有關學者共同遴選組成。
審議會由委員相互推選一人為主席。
審議會委員均為無給職。
審議會之任務如下：
一、審查獎勵對象之資格。
二、審議各項獎勵申請案件。
三、核定獎勵名額及核給獎勵點數。
四、其他依本辦法應經審議會審議之事項。